Skip to main content
Sequana Medical N.V. logo

Sequana Medical N.V. — Investor Relations & Filings

Ticker · SEQUA ISIN · BE0974340722 LEI · 8755009AN12Y4PEOII07 BR Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2026-05-28 Declaration of Voting R…
Country BE Belgium
Listing BR SEQUA

About Sequana Medical N.V.

https://www.sequanamedical.com/

Sequana Medical N.V. is a commercial-stage medical device company focused on developing treatments for drug-resistant fluid overload, a frequent complication in patients with liver disease, heart failure, and cancer. The company's primary product is the alfapump®, a fully implanted, wirelessly charged system that automatically and continuously removes ascites (fluid accumulation in the abdomen) into the bladder for natural elimination. It is the first U.S. FDA-approved active implantable medical device for treating recurrent or refractory ascites due to liver cirrhosis, designed to reduce or eliminate the need for therapeutic paracentesis. Sequana Medical is also advancing its DSR® (Direct Sodium Removal) therapy platform, a novel approach for managing fluid overload in heart failure patients.

Recent filings

Filing Released Lang Actions
Sequana Medical -- AGM 2026 -- PR Results AGM (ENG) (28 May 2026).pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 89% confidence The document is a press release explicitly announcing the results of an Annual General Meeting of Shareholders, detailing which agenda items were approved and adjourned. This corresponds to the category for official shareholder vote results at a general meeting.
2026-05-28 English
Sequana Medical -- AGM 2026 -- PR Results AGM (NL) (28 May 2026).pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a press release (“Persbericht”) announcing the results of the Ordinary General Meeting of Shareholders (“Gewone Algemene Vergadering van Aandeelhouders”), detailing which agenda items were approved or deferred. It reports vote outcomes from an AGM but does not include financial statements or substantive financial data. This fits the Declaration of Voting Results & Voting Rights Announcements category (DVA).
2026-05-28 Dutch
Sequana Medical -- AGM 2026 -- AGM Minutes (ENG) (28 May 2026).pdf
AGM Information Classification · 93% confidence The document is the formal minutes of the company’s Ordinary General Shareholders’ Meeting, including agenda items, proposed resolutions, and meeting composition. It is not merely a notice of report publication or vote results but the actual AGM documentation. Therefore it falls under AGM Information (AGM-R).
2026-05-28 English
Sequana Medical -- AGM 2026 -- AGM Minutes (NL) (28 May 2026).pdf
AGM Information Classification · 88% confidence The document is titled “Notulen van de gewone algemene vergadering van aandeelhouders” (Minutes of the ordinary general shareholders’ meeting) held on 28 May 2026. It consists of the formal record of the AGM proceedings, agenda items, and proposed resolutions. This clearly places it in the category of AGM Information rather than a financial report, regulatory notice, or voting-results-only announcement.
2026-05-28 Dutch
Convening Notice (ENG) (28 April 2026).pdf
AGM Information Classification · 100% confidence The document is an invitation to the Ordinary General Shareholders' Meeting (AGM) of Sequana Medical NV, scheduled for 28 May 2026. It contains the agenda and proposed resolutions for the meeting, including discussion and approval of statutory and consolidated financial statements, discharge of liability for directors and auditors, approval of the remuneration report, re-appointment of directors, and a resolution regarding the continuation of the company. The document does not contain the actual financial statements or reports but refers to their availability on the company's website and notes that treatment of some agenda items will be adjourned due to the unavailability of these reports at the time of convening. The document is a meeting invitation and agenda, not the actual annual report or financial statements. Therefore, it fits the definition of AGM Information (AGM-R).
2026-04-28 English
Board Report 7_228 (Financial Alarm Bell) (ENG) (28 April 2026).pdf
Board/Management Information Classification · 95% confidence The document is a report prepared by the board of directors in accordance with article 7:228 of the Belgian Companies and Associations Code. It discusses the company's financial situation, specifically the net assets falling below legal thresholds, the current financial position, cash runway, and proposed measures by the board to address liquidity and going concern issues. The document is a formal report from the board of directors addressing financial distress and compliance with legal requirements related to net asset thresholds. It is not a full annual or interim financial report, nor is it an announcement of voting results or a regulatory filing. The content aligns with a Board/Management Information report, as it involves the board's assessment and proposed actions regarding the company's financial condition and governance matters. The document length (9784 characters) and detailed content support classification as a Board/Management Information report rather than a brief announcement or certification.
2026-04-28 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.